No Images? Click here ACMT CONNECTION E-News: DECEMBER 2018 New Position Statement on Buprenorphine ACMT supports the administration of buprenorphine in the ED as a bridge to long-term addiction treatment. Our Position Statements and Guidelines Committee published 'Buprenorphine Administration in the Emergency Department' on Dec. 12. Make Your 2018 Annual Campaign Donation MTF has funded more than $205,000 in grants and travel awards to Medical Toxicologists. Help us exceed our 2018 Annual Campaign goal of $70,000 in ACMT member donations! Read about award recipients and how they are using MTF funding to advance the field. $50,000 Grant Received for Opioid Treatment Education MTF received $50,000 in support from the Independence Blue Cross Foundation under the Supporting Treatment and Overdose Prevention (STOP) program. These funds will support Curbing the Opioid Crisis in Philadelphia: Increasing Emergency Department Initiation of Buprenorphine-Naloxone Treatment for Opioid Use Disorder initiative. PI: Jeanmarie Perrone, MD, FACMT Member Leadership Update Congratulations to new ACMT Executive Committee member:
Congratulations to new and continuing Board of Directors elected members:
2018 ACMT Year in Review Executive Director Paul Wax, MD, FACMT, shares highlights from the year, including successful conferences, ACMT's 25th Anniversary, and milestone staff anniversaries. 2019 MTF Awards and Grants Innovative Research and Teaching Award: Request grant dollars from $5,000—$20,000! Join us at a submission planning webinar on Jan. 8 at 1pm EST. Applications due Feb. 15, 2019. MTF/EMF Research Grant: Request a $10,000 grant! Applications due Feb 28, 2019 Register Today: 2019 ACMT Annual Scientific Meeting and Satellite Sessions We are hosting TWO Satellite Sessions on April 11:
Early Bird deadline is Feb. 1! PEHSU National Classroom - New Learning Opportunities Enroll in PEHSU webinars anytime! New classes include:
January Tweetchat Join us at #firesidetox on Jan. 15 at 3:00pm EST to discuss the ACMT Position Statement: Alternative or Contingency Countermeasures for Acetylcholinesterase Inhibiting Agents |